The 2023 Precancer Atlas Research Symposium

---

Friday, March 24, 2023, 9:00 AM - 5:00 PM, MD Anderson - Duncan Building, Houston, TX


Non-Accredited (9.00 hours)

MD Anderson’s Precancer Atlas (PCA) is an institutionally funded initiative designed to comprehensively assess pre-cancers from different organ sites with the long-term goals of (i) discovering interventions for enabling cancer interception; and (ii) accelerating the development of biomarkers for cancer risk stratification and early detection.

 The PCA Research Symposium will feature internationally renowned experts in the fields of premalignant biology, immunology and cancer interception discussing the current and future state of precancer research and the most promising strategies to translate this work into novel preventive interventions. Confirmed keynote speakers include: James Allison.

The event is offered at no charge and is open to all MD Anderson faculty, staff and trainees only.

Advanced registration is encouraged as space is limited.

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.